JKS [JinkoSolar] 6-K: (Original Filing)

[JinkoSolar Announces Completion of Repurchase of 4.00% Convertible Senior Notes due 2019 SHANGHAI, Feb. 21, 2017 -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), a global leader in the photovoltaic ("PV") industry, today announced that it has completed the repurchase of c]

By | 2017-02-23T15:04:43+00:00 February 23rd, 2017|Categories: Chinese Stocks, JKS, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: FOR RELEASE February 23, 2017 China Biologic Reports

[FOR RELEASE February 23, 2017 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 -- 4Q16 Total Sales Up 13.6% YoY to $77.6 Million and Net Income Up 19.0% YoY to $19.4 Million in USD terms, or Total Sales Up 21.7% YoY and Non-GAAP Adjusted Net Income Up 40.7% YoY in]

By | 2017-02-24T03:11:44+00:00 February 23rd, 2017|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

JKS [JinkoSolar] 6-K: JinkoSolar Announces Completion of Repurchase of 4.00% Convertible

[JinkoSolar Announces Completion of Repurchase of 4.00% Convertible Senior Notes due 2019 SHANGHAI, Feb. 21, 2017 -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), a global leader in the photovoltaic ("PV") industry, today announced that it has completed the repurchase of c]

By | 2017-02-23T15:05:07+00:00 February 23rd, 2017|Categories: Chinese Stocks, JKS, Webplus ver|Tags: , , , , , |0 Comments

CTRP [CTRIP COM INTERNATIONAL] 6-K: (Original Filing)

[Ctrip Reports Unaudited Fourth Quarter and Full Year 2016 Financial Results Shanghai, China, February 22, 2017 - Ctrip.com International, Ltd. (Nasdaq: CTRP), a leading travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management in C]

By | 2017-02-23T15:06:15+00:00 February 23rd, 2017|Categories: Chinese Stocks, CTRP, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] IRANNOTICE: (Original Filing)

[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China February 23, 2017 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat ]

CTRP [CTRIP COM INTERNATIONAL] 6-K: Ctrip Reports Unaudited Fourth Quarter and Full Year

[Ctrip Reports Unaudited Fourth Quarter and Full Year 2016 Financial Results Shanghai, China, February 22, 2017 - Ctrip.com International, Ltd. (Nasdaq: CTRP), a leading travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management in C]

By | 2017-02-23T15:06:37+00:00 February 23rd, 2017|Categories: Chinese Stocks, CTRP, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] IRANNOTICE: China Biologic Products, Inc. 8th Floor, Jialong International

[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China February 23, 2017 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat ]

TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: (Original Filing)

[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer Taiwan Semiconductor Manufacturing Company Limited 1) The changes in the shareholdings of our board directors, executive officers and shareholders who own more than 10% of total outstanding com]

By | 2017-02-23T15:07:35+00:00 February 23rd, 2017|Categories: Chinese Stocks, SEC Original, TSM|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-K: (Original Filing)

[Annual Report on Form 10-K Year Ended December 31, 2016 TABLE OF CONTENTS PART I Item 1. Business 3 Item 1A. Risk Factors 24 Item 1B. Unresolved Staff Comments 45 Item 2. Properties 45 Item 3. Legal Proceedings 46 Item 4. Mine Safety Disclosures 48 PART II Item 5. 49 Item 6. Selected Financial Data ]

Skip to toolbar